3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
20
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Prostatic Neoplasms
46
Kidney Neoplasms
11
Carcinoma, Renal Cell
11
Urinary Bladder Neoplasms
9
Neoplastic Cells, Circulating
8
Neoplasms
8
Breast Neoplasms
7
Neoplasm Metastasis
5
Melanoma
5
Sarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Testicular Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Disease
3
Colorectal Neoplasms
3
von Hippel-Lindau Disease
2
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Prostatic Hyperplasia
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Liver Neoplasms
2
Leukemia
2
Kidney Diseases
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
pembrolizumab
23
Nivolumab
20
atezolizumab
10
Specimen Handling
8
Ipilimumab
8
Cyclophosphamide
8
cabozantinib
6
Magnetic Resonance Spectroscopy
6
fludarabine
5
Sorafenib
5
sargramostim
4
Trastuzumab
4
Sunitinib
4
Bevacizumab
4
lenvatinib
3
enzalutamide
3
durvalumab
3
avelumab
3
X-Rays
3
Paclitaxel
3
Fluorodeoxyglucose F18
3
Docetaxel
3
Albumin-Bound Paclitaxel
3
ulixertinib
2
spartalizumab
2
relatlimab
2
regorafenib
2
palbociclib
2
epacadostat
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Blood Specimen Collection
×
Genitourinary
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled